{
  "trial_id": "NCT01100931",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, ECOG performance status, Absolute neutrophil count (ANC), Hemoglobin level, Platelet count, Serum creatinine level, Creatinine clearance, Aspartate aminotransferase (AST) level, Alanine aminotransferase (ALT) level, Total bilirubin level, HIV status, Pregnancy test result (for females), Contraception use, Histological or cytological evidence of non-small cell lung cancer, Metastatic disease or stage IIIB non-small cell lung cancer status, Prior chemotherapy for advanced lung cancer, Measurable disease status, History of myocardial infarction, History of unstable angina pectoris, History of uncontrolled hypertension, History of coronary/peripheral artery bypass graft, NYHA class III or IV congestive heart failure status, History of stroke or transient ischemic attack, History of pulmonary embolism or deep venous thrombosis, Psychiatric or neurologic illness status, History of severe active infection, Use of other investigational agents, History of active malignancy, History of hypersensitivity reaction to similar compounds, History of major surgical procedure or significant traumatic injury, Other serious illness or medical condition status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Pregnancy test result (for females)"
        ],
        [
          "Male",
          "Gender"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "Absolute neutrophil count (ANC)",
        "Hemoglobin level",
        "Platelet count",
        "Serum creatinine level",
        "Creatinine clearance",
        "Aspartate aminotransferase (AST) level",
        "Alanine aminotransferase (ALT) level",
        "Total bilirubin level",
        "HIV status",
        "Contraception use",
        "Histological or cytological evidence of non-small cell lung cancer",
        "Metastatic disease or stage IIIB non-small cell lung cancer status",
        "Prior chemotherapy for advanced lung cancer",
        "Measurable disease status",
        "History of myocardial infarction",
        "History of unstable angina pectoris",
        "History of uncontrolled hypertension",
        "History of coronary/peripheral artery bypass graft",
        "NYHA class III or IV congestive heart failure status",
        "History of stroke or transient ischemic attack",
        "History of pulmonary embolism or deep venous thrombosis",
        "Psychiatric or neurologic illness status",
        "History of severe active infection",
        "Use of other investigational agents",
        "History of active malignancy",
        "History of hypersensitivity reaction to similar compounds",
        "History of major surgical procedure or significant traumatic injury",
        "Other serious illness or medical condition status"
      ]
    },
    "processed-gen-response": "Age, Gender, ECOG performance status, Absolute neutrophil count (ANC), Hemoglobin level, Platelet count, Serum creatinine level, Creatinine clearance, Aspartate aminotransferase (AST) level, Alanine aminotransferase (ALT) level, Total bilirubin level, HIV status, Pregnancy test result (for females), Contraception use, Histological or cytological evidence of non-small cell lung cancer, Metastatic disease or stage IIIB non-small cell lung cancer status, Prior chemotherapy for advanced lung cancer, Measurable disease status, History of myocardial infarction, History of unstable angina pectoris, History of uncontrolled hypertension, History of coronary/peripheral artery bypass graft, NYHA class III or IV congestive heart failure status, History of stroke or transient ischemic attack, History of pulmonary embolism or deep venous thrombosis, Psychiatric or neurologic illness status, History of severe active infection, Use of other investigational agents, History of active malignancy, History of hypersensitivity reaction to similar compounds, History of major surgical procedure or significant traumatic injury, Other serious illness or medical condition status."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Absolute Neutrophil Count (ANC), Hemoglobin, Platelet Count, Serum Creatinine, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Total Bilirubin, HIV Status, Pregnancy Test (for females), Prior Chemotherapy Regimen, Measurable Disease by RECIST Criteria, History of Cardiovascular Events, History of Stroke or Transient Ischemic Attack, History of Thrombo-embolic Events, Psychiatric or Neurologic Illness, Active Infection, Prior Investigational Agents, History of Active Malignancy, History of Hypersensitivity Reaction, Major Surgical Procedure History, Other Serious Illness or Medical Condition,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "ECOG Performance Status",
        "Absolute Neutrophil Count (ANC)",
        "Hemoglobin",
        "Platelet Count",
        "Serum Creatinine",
        "Aspartate Aminotransferase (AST)",
        "Alanine Aminotransferase (ALT)",
        "Total Bilirubin",
        "HIV Status",
        "Pregnancy Test (for females)",
        "Prior Chemotherapy Regimen",
        "Measurable Disease by RECIST Criteria",
        "History of Cardiovascular Events",
        "History of Stroke or Transient Ischemic Attack",
        "History of Thrombo-embolic Events",
        "Psychiatric or Neurologic Illness",
        "Active Infection",
        "Prior Investigational Agents",
        "History of Active Malignancy",
        "History of Hypersensitivity Reaction",
        "Major Surgical Procedure History",
        "Other Serious Illness or Medical Condition"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Absolute Neutrophil Count (ANC), Hemoglobin, Platelet Count, Serum Creatinine, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Total Bilirubin, HIV Status, Pregnancy Test (for females), Prior Chemotherapy Regimen, Measurable Disease by RECIST Criteria, History of Cardiovascular Events, History of Stroke or Transient Ischemic Attack, History of Thrombo-embolic Events, Psychiatric or Neurologic Illness, Active Infection, Prior Investigational Agents, History of Active Malignancy, History of Hypersensitivity Reaction, Major Surgical Procedure History, Other Serious Illness or Medical Condition"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Histology of Tumor, Number of Prior Chemotherapy Regimens, Presence of Brain Metastases, Presence of Liver Metastases, Baseline Hemoglobin, Baseline Absolute Neutrophil Count, Baseline Platelet Count, Baseline Creatinine Clearance, Baseline Aspartate Aminotransferase, Baseline Alanine Aminotransferase, Baseline Total Bilirubin.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "ECOG Performance Status",
        "Histology of Tumor",
        "Number of Prior Chemotherapy Regimens",
        "Presence of Brain Metastases",
        "Presence of Liver Metastases",
        "Baseline Hemoglobin",
        "Baseline Absolute Neutrophil Count",
        "Baseline Platelet Count",
        "Baseline Creatinine Clearance",
        "Baseline Aspartate Aminotransferase",
        "Baseline Alanine Aminotransferase",
        "Baseline Total Bilirubin"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Histology of Tumor, Number of Prior Chemotherapy Regimens, Presence of Brain Metastases, Presence of Liver Metastases, Baseline Hemoglobin, Baseline Absolute Neutrophil Count, Baseline Platelet Count, Baseline Creatinine Clearance, Baseline Aspartate Aminotransferase, Baseline Alanine Aminotransferase, Baseline Total Bilirubin."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG performance status, Karnofsky performance score, presence of brain metastases, number of prior chemotherapy regimens, prior treatment with bevacizumab, tumor histology, tumor stage, presence of metastatic disease, measurable disease, prior surgery or radiation therapy, smoking history, medical history (including hypertension, cardiovascular disease, pulmonary disease, etc.), laboratory values (including hemoglobin, ANC, platelets, creatinine, AST, ALT, bilirubin, etc.).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "Karnofsky performance score",
        "presence of brain metastases",
        "number of prior chemotherapy regimens",
        "prior treatment with bevacizumab",
        "tumor histology",
        "tumor stage",
        "presence of metastatic disease",
        "measurable disease",
        "prior surgery or radiation therapy",
        "smoking history",
        "medical history (including hypertension, cardiovascular disease, pulmonary disease, etc.)",
        "laboratory values (including hemoglobin, ANC, platelets, creatinine, AST, ALT, bilirubin, etc.)"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, ECOG performance status, Karnofsky performance score, presence of brain metastases, number of prior chemotherapy regimens, prior treatment with bevacizumab, tumor histology, tumor stage, presence of metastatic disease, measurable disease, prior surgery or radiation therapy, smoking history, medical history (including hypertension, cardiovascular disease, pulmonary disease, etc.), laboratory values (including hemoglobin, ANC, platelets, creatinine, AST, ALT, bilirubin, etc.)."
  }
}